Caption Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $129K | Buy |
41,866
+17,669
| +73% | +$54.6K | ﹤0.01% | 443 |
|
|
2025
Q1 | $84.4K | Sell |
24,197
-45,403
| -65% | -$158K | ﹤0.01% | 458 |
|
|
2024
Q4 | $228K | Buy |
+69,600
| New | +$228K | ﹤0.01% | 381 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 397 |
|
|
2024
Q1 | – | Sell |
-42,736
| Closed | -$107K | – | 374 |
|
|
2023
Q4 | $107K | Buy |
42,736
+40,065
| +1,500% | +$100K | ﹤0.01% | 339 |
|
|
2023
Q3 | $5.42K | Buy |
+2,671
| New | +$5.42K | ﹤0.01% | 398 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 346 |
|
|
2023
Q1 | – | Sell |
-50,000
| Closed | -$117K | – | 334 |
|
|
2022
Q4 | $117K | Buy |
50,000
+16,216
| +48% | +$37.8K | ﹤0.01% | 329 |
|
|
2022
Q3 | $64K | Sell |
33,784
-17,016
| -33% | -$32.2K | ﹤0.01% | 428 |
|
|
2022
Q2 | $138K | Buy |
50,800
+31,720
| +166% | +$86.2K | ﹤0.01% | 378 |
|
|
2022
Q1 | $58K | Buy |
19,080
+3,983
| +26% | +$12.1K | ﹤0.01% | 460 |
|
|
2021
Q4 | $59K | Buy |
15,097
+8,199
| +119% | +$32K | ﹤0.01% | 512 |
|
|
2021
Q3 | $30K | Sell |
6,898
-31,802
| -82% | -$138K | ﹤0.01% | 497 |
|
|
2021
Q2 | $118K | Buy |
+38,700
| New | +$118K | ﹤0.01% | 366 |
|
|
2019
Q1 | – | Sell |
-5,000
| Closed | -$20K | – | 190 |
|
|
2018
Q4 | $20K | Buy |
+5,000
| New | +$20K | ﹤0.01% | 191 |
|